MedTrace Logo

Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

NCT03818932 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-03-19

Study results available
· View outcomes & findings →

Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligament reconstruction: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Conditions

  • Anterior Cruciate Ligament Injury

Interventions

DRUG

Celecoxib

Post-Operative Non Opioid Pain Protocol

DRUG

Hydrocodone-Acetaminophen

Traditionally used narcotic pain protocol

DRUG

Ketorolac

Post-Operative Non Opioid Pain Protocol

DRUG

Gabapentin

Post-Operative Non Opioid Pain Protocol

DRUG

Acetaminophen

Post-Operative Non Opioid Pain Protocol

DRUG

Diazepam

Post-Operative Non Opioid Pain Protocol

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Toufic R Jildeh, MD · Resident

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2020-01-20
Completion
2020-05-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03818932 on ClinicalTrials.gov